GLP-1 receptor agonist
Semaglutide in Canada
Semaglutide is the single-agonist GLP-1 research peptide — the same molecule marketed under the brand names Ozempic and Wegovy as a prescription medicine. Canada Peptides carries research-grade semaglutide, priced and shipped in CAD. Everything below is for research and educational use only.
Semaglutide — for sale
What is semaglutide?
Semaglutide is a GLP-1 receptor agonist — a long-acting peptide that binds and activates the GLP-1 receptor. It is the single-agonist member of the incretin class and the most clinically characterised of the group, which is why it anchors most GLP-1 research comparisons. For the full mechanism, see the semaglutide research overview.
Semaglutide, Ozempic, and Wegovy
Ozempic and Wegovy are brand names under which semaglutide is marketed as a prescription medicine. The material sold here is research-grade semaglutide, supplied strictly for laboratory research use — it is not the branded pharmaceutical and is not for human use.
Semaglutide vs tirzepatide and retatrutide
By receptor coverage: semaglutide is a single GLP-1 agonist, tirzepatide is a dual GLP-1/GIP agonist, and retatrutide is a triple GLP-1/GIP/glucagon agonist. The GLP-1 receptor agonists comparison breaks down how the three differ mechanistically.
Dosing in research
Published protocols for semaglutide use once-weekly subcutaneous administration with gradual titration. Our dosing-math and reconstitution guides cover the handling math. This is research context only — not a dosing recommendation for human use.
How to get semaglutide in Canada
Research-grade semaglutide is available to order on this page, shipped within Canada in CAD for research use only. Reconstitution and handling guidance is linked above.
Further reading
Semaglutide vs Tirzepatide — compared
Semaglutide vs tirzepatide compared on mechanism, half-life, and the head-to-head trial data from SURPASS-2 and SURMOUNT-5 — including where the cardiovascular evidence still diverges.
Semaglutide dosage — research dosing notes
A research-literature overview of semaglutide dosage: the STEP and SUSTAIN escalation schedules, the 7-day half-life behind the four-week cadence, and the reconstitution math from lyophilized vial to syringe units.
Generic Semaglutide in Canada: What Health Canada's 2026 Approvals Mean
Canada is the first G7 country to approve generic semaglutide. What Health Canada approved in 2026, why the patent lapsed, pricing and availability — and how prescription generics differ from research-grade semaglutide.
Semaglutide Side Effects: What the Research Reports
What the published literature reports about semaglutide's tolerability and side-effect profile, framed for research. Research use only, not medical advice.
Is Semaglutide the Same as Ozempic? Semaglutide vs Ozempic
Semaglutide vs Ozempic — the difference between a compound and its brand names. Ozempic and Wegovy are semaglutide; what research-grade semaglutide is and isn't. Research use only.
Semaglutide Dosing: A Research Reference
How semaglutide is dosed in published research — once-weekly administration, titration, and reconstitution math. Research use only, not medical advice.
Semaglutide FAQ
- Is semaglutide for sale in Canada?
- Yes. Research-grade semaglutide is available in Canada from Canada Peptides, priced and shipped in CAD. It is supplied strictly for laboratory and research use.
- How can I get semaglutide in Canada?
- You can order research-grade semaglutide directly on this page. It ships within Canada in CAD, for research use only.
- Is semaglutide the same as Ozempic or Wegovy?
- Ozempic and Wegovy are brand names under which semaglutide is marketed as a prescription medicine. The material sold here is research-grade semaglutide supplied strictly for laboratory research use — it is not the branded pharmaceutical and is not for human use.
- What is semaglutide?
- Semaglutide is a GLP-1 receptor agonist: a long-acting peptide that binds and activates the GLP-1 receptor. It is the single-agonist member of the incretin class and the most clinically characterised of the group.
- Semaglutide vs tirzepatide vs retatrutide — what's the difference?
- By receptor coverage: semaglutide is a single GLP-1 agonist, tirzepatide is a dual GLP-1/GIP agonist, and retatrutide is a triple GLP-1/GIP/glucagon agonist. See the GLP-1 receptor agonists comparison for how they differ.
- Is semaglutide research use only?
- Yes. The semaglutide sold here is supplied strictly for laboratory and research use. Nothing on this page is medical advice or a therapeutic claim.
Research & educational use only. This page is informational and does not constitute medical advice or a therapeutic claim.